1. Home
  2. Downgrades

Downgrades

Chinese EV Stocks Li Auto, BYD, Nio To Benefit From Rebound: Analyst

Macquarie Equity Research issued a positive outlook for the short-term Chinese EV market following a $142 billion (one trillion yuan) stimulus package. Analysts listed several positive catalysts, including new model launches, expanded margins due to operating leverage, the end of subsidies pulling demand forward, reduced discounting pressures and clarity on potential European Union (EU) tariffs, […]

Warner Music Hit By Streaming Volatility And Execution Risks: Analyst

BofA Securities analyst Jessica Reif Ehrlich downgraded Warner Music Group Corp (NASDAQ:WMG) from Neutral to Underperform and lowered the price target from $33 to $30. The price target is approximately 12 times the calendar year 2025 OIBDA (previously 13 times the 2025 OIBDA). Given the analyst’s better long-term growth outlook, the multiple represents an approximately 25% premium to […]

Stellantis In Hot Water: Analyst Downgrades Stock Due To Downward Pricing Pressure And Inventory Issues

RBC Capital analyst Tom Narayan downgrades Stellantis (NYSE:STLA) from Outperform to Sector Perform, lowering the price forecast for the Paris-listed stock to 13 euros ($14.25) from 17 euros. The analyst notes that if the company can resolve its inventory issues without sacrificing prices, margins could rebound to double digits, which would be competitive with Ford […]

Canadian National Railways Faces Rising Earnings Pressure And Network Challenges, Analyst Downgrades Stock

BofA Securities analyst Ken Hoexter downgraded Canadian National Railway Company (NYSE:CNI) to Neutral from Buy, lowering the price forecast from $129 to $122 amid “rising earnings pressure.” According to the analyst, the company’s third-quarter volumes have been affected by ongoing network performance challenges following the labor lockout of Conductor/Engineer staff in August. The analyst estimates 2024 EPS […]

This Tractor Supply Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham analyst Serge Belanger downgraded the rating for Verrica Pharmaceuticals (NASDAQ:VRCA) from Buy to Hold and maintained a $12 price target. Verrica Pharmaceuticals shares dipped […]

SAIC’s $130B Pipeline Boosts Outlook, Booz Allen Faces Valuation Challenge, Says JP Morgan

JP Morgan analyst Seth M. Seifman changed the rating on federal IT services companies, Science Applications International Corporation (NASDAQ:SAIC) and Booz Allen Hamilton Holding Corporation (NYSE:BAH). The analyst upgraded Science Applications to Overweight from Neutral and raised the price target to $170 from $150. During the April Investor Day, management emphasized plans to transition SAIC […]

Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data ‘Insufficient To Excite Many Investors’

On Monday, Gritstone Bio Inc. (NASDAQ:GRTS) revealed interim Phase 2 data from the ongoing Phase 2 study evaluating GRANITE, its individualized neoantigen-targeting immunotherapy, in frontline microsatellite-stable colorectal cancer (MSS-CRC). The study is designed to evaluate the clinical benefit of maintenance therapy with GRANITE (GRT-C901/GRT-R902) in combination with immune checkpoint inhibitors in addition to fluoropyrimidine/bevacizumab versus fluoropyrimidine/bevacizumab […]